VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
about
P1343
Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potentialMelanoma: oncogenic drivers and the immune systemNovel Immune Check-Point Regulators in Tolerance MaintenanceBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsUnderstanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpointsMolecular mechanisms of T cell co-stimulation and co-inhibitionFunctional Classification of Immune Regulatory ProteinsCombination Approaches with Immune-Checkpoint Blockade in Cancer TherapyTargeting immune checkpoints in malignant gliomaIs There Still Room for Cancer Vaccines at the Era of Checkpoint InhibitorsPD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinationsImmune checkpoint blockade: a common denominator approach to cancer therapyThe future of immune checkpoint therapyThe immunoglobulin superfamily protein differentiation of embryonic stem cells 1 (dies1) has a regulatory role in preadipocyte to adipocyte conversionThe novel negative checkpoint regulator VISTA is expressed in gastric carcinoma and associated with PD-L1/PD-1: A future perspective for a combined gastric cancer therapy?Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis.VISTA Regulates the Development of Protective Antitumor Immunity.An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling.Nardilysin-dependent proteolysis of cell-associated VTCN1 (B7-H4) marks type 1 diabetes development.Characterization of programmed death-1 homologue-1 (PD-1H) expression and function in normal and HIV infected individuals.Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.VISTA is an immune checkpoint molecule for human T cells.Coinhibitory receptor PD-1H preferentially suppresses CD4⁺ T cell-mediated immunityControl of signaling-mediated clearance of apoptotic cells by the tumor suppressor p53New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escapeMechanistic Assessment of PD-1H Coinhibitory Receptor-Induced T Cell Tolerance to Allogeneic Antigens.Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.Selective Involvement of the Checkpoint Regulator VISTA in Suppression of B-Cell, but Not T-Cell, Responsiveness by Monocytic Myeloid-Derived Suppressor Cells from Mice Infected with an Immunodeficiency-Causing RetrovirusInhibitory receptors as targets for cancer immunotherapyNovel cancer immunotherapy agents with survival benefit: recent successes and next steps.Targeting the B7 family of co-stimulatory molecules: successes and challenges.Immunomodulatory therapy for melanoma: ipilimumab and beyondAdvances in targeting cell surface signalling molecules for immune modulationCoinhibitory Pathways in the B7-CD28 Ligand-Receptor Family.Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1.Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.A New VISTA on combination therapy for negative checkpoint regulator blockade.Emerging roles of p53 and other tumour-suppressor genes in immune regulationA VISTA on PD-1H.
P2860
Q26769884-B15E16F6-F749-4EC3-A894-1009FA4F3F58Q26775598-858F8059-86C8-4983-BCF8-7ECD36A074AFQ26782789-DAF71BE9-05FB-4B42-B258-83597D53E923Q26782799-D0F67112-2CC5-4698-ADF9-865F6B95266AQ26801551-E3F77944-A658-4104-B4F7-90E03F41BF0DQ26864888-38AA122A-48BF-4CF3-B0B4-41B1D1BDE9EEQ27677346-C777F84B-C121-4C2D-8874-A4EB398289CFQ28066199-A06372DB-7481-44ED-B6EC-C263BE252A91Q28072012-A094841C-D8D8-4A99-BB37-D495DC9936BCQ28072532-0CF3809F-B947-4782-BCC4-C02B32C390A9Q28075712-3C329A91-D022-43DF-91B5-299288BB6409Q28083981-586736B2-DD53-4D8C-9204-2DBB4EAF0982Q28259862-8485BE07-EFFA-4365-AC10-8A32FB830D67Q31120243-9EA020D9-E90C-40C1-8F20-1BB5934EDD97Q33632116-9C08F07B-1073-4CA6-80D4-46E4FA5F0EE5Q33930609-40419012-7F16-4EA8-96B3-2E0C22F7B8EAQ33978040-F34251BA-A8F1-44E3-8036-18BC5F2E534BQ33987134-E7228FC0-2504-4176-8762-C1D8BCF43B44Q34227834-84B3E410-86F1-4AA4-8BB4-C2AE090FE654Q34287251-00F07517-C5C3-4915-9EE7-F7885C721DDDQ34384017-163DD18B-AB98-4028-9A25-E9380BF7A808Q34413221-ABE227CD-B70E-492B-92CE-DCC4652E5107Q34415743-D6F7EBE9-9205-42EF-9EE2-8D4ABAE69A93Q34487653-61CB12F1-CDAB-460D-9814-821901BE8026Q35300077-58D57CCD-F70D-46EE-82F1-F69D42F4E2AEQ35613336-E6F50C5F-FE9E-4530-BAA3-A66D6334E477Q35669414-9E51864E-4C5E-40DA-944D-DD4002D96429Q35973689-459611D2-EF84-49B7-993E-AB4274F5637AQ35995373-3CFC7181-E985-4075-82D0-CF17FF3B4387Q36185518-1828256A-BE02-4371-BAD9-B10E546F6FCEQ36841260-28A7FD36-E922-439E-B399-073A0CB15487Q36841621-D217EDF8-2581-4401-9236-4F2896B3A5CAQ36973787-8C4A338A-76FE-4A90-BDFE-875EA6B8A7E9Q36998864-CB406E6B-3E1F-4E32-9F47-A8FC27C90892Q37007501-38B34873-23F6-4A82-A43A-67F94F76D638Q37158481-7A60ED10-5EFF-4661-9651-ABEA09578E8DQ37224577-BC57178C-4828-440D-BB54-8744AE79257EQ37517581-FB1EFD8F-9330-4B5C-8B06-88B7F55F6946Q37666015-ED3FBB47-C9F2-4B4B-90E0-4D654A448A45Q37726700-A0AA6F47-6349-45D2-B778-F50F610E4D36
P2860
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
description
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2011
@ast
im März 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2011/03/14)
@sk
vědecký článek publikovaný v roce 2011
@cs
wetenschappelijk artikel (gepubliceerd op 2011/03/14)
@nl
наукова стаття, опублікована в березні 2011
@uk
مقالة علمية (نشرت في 14-3-2011)
@ar
name
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@ast
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@en
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@nl
type
label
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@ast
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@en
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@nl
prefLabel
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@ast
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@en
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@nl
P2093
P2860
P3181
P356
P1476
VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
@en
P2093
Andras Fiser
Cory Ahonen
David Gondek
Janet L Lines
Randolph J Noelle
Rotem Rubinstein
Roy A Fava
Steve Almo
P2860
P304
P3181
P356
10.1084/JEM.20100619
P407
P577
2011-03-07T00:00:00Z